Acular is primarily indicated for short-term postoperative inflammation and pain. Long-term use has not been studied, and chronic exposure may increase the risk of corneal complications. Patients with persistent ocular irritation should discuss alternative treatments with their eye specialist.
The Acular bottle is a small, amber-colored plastic container with a twist-off cap. The label typically displays the brand name “Acular,” the concentration “0.4 %,” and a unique batch number. The imprint on the cap may include the MHRA marketing authorization number for verification.
In the UK, the use of Acular does not appear on the list of substances that disqualify pilots from medical certification, provided the medication is used as prescribed and does not impair visual acuity. Pilots should report any temporary vision changes to their aviation medical examiner.
Acular, an NSAID, reduces inflammation by inhibiting prostaglandin synthesis, whereas steroid eye drops suppress a broader range of inflammatory pathways, including cytokine production. NSAIDs like Acular carry a lower risk of raising intra-ocular pressure but may be less potent in severe inflammation compared with steroids.
Systemic absorption from the ophthalmic solution is minimal, so significant interaction with oral anticoagulants is unlikely. However, clinicians may monitor INR levels when patients use both Acular and high-dose systemic NSAIDs alongside warfarin.
Yes, Acular is permitted in hand luggage provided the bottle is under 100 ml and the original packaging is retained. Travelers should carry a copy of the prescription or a doctor’s note in case security personnel request verification.
Ketorolac trometamol ophthalmic formulations were originally patented by the brand developer, but the patent has expired, allowing generic versions to be marketed. Acular remains a branded product, but equivalent generic eye drops are available after patent expiry.
Exposure to temperatures above 30 °C can degrade the active ingredient and compromise sterility. It is advisable to keep Acular in a cool, dry place and avoid leaving the bottle in a vehicle on hot days.
Unused Acular should be returned to a pharmacy’s medication-take-back program or disposed of according to NHS guidelines for hazardous waste. Do not flush the solution down the toilet or pour it into the household drain.
Acular may be prescribed on the NHS for eligible indications, with the cost determined by the NHS Drug Tariff. Generic ketorolac ophthalmic solutions are typically less expensive, but the price difference varies by pharmacy and bulk purchasing agreements.
Acular is an ophthalmic solution that contains ketorolac trometamol as its active ingredient. It belongs to the non-steroidal anti-inflammatory drug (NSAID) class and is formulated as a 0.4 % eye-drop solution packaged in a bottle. In the United Kingdom, Acular is a prescription-only medication (Prescription Only Medicine, POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Ketorolac trometamol inhibits the cyclooxygenase (COX) enzymes 1 and 2, which are responsible for converting arachidonic acid into prostaglandins. Prostaglandins mediate inflammation, pain, and swelling in ocular tissues. By reducing prostaglandin synthesis, Acular lowers inflammation and alleviates pain following eye surgery or other ocular irritation. The drug is rapidly absorbed through the cornea, with peak ocular concentrations reached within a few minutes and a short systemic exposure because of the low dose and limited systemic absorption.
Acular is approved by the MHRA for the treatment of:
The medication is intended for adult patients; the safety and efficacy in children have not been established.
Special populations should discuss risks with a healthcare professional before initiating therapy.
Administration tips
Missed dose
If a dose is missed, administer it as soon as remembered unless the next scheduled dose is within a short interval (less than 2 hours). In that case, skip the missed dose-do not double-dose.
Overdose
Symptoms of overdose may include severe eye irritation, corneal edema, or systemic signs such as nausea. Seek urgent medical care or contact the local poison information service (e.g., NHS Poisons Information Helpline).
Discontinuation
Acular can be stopped without tapering because it does not cause physiological dependence. However, sudden cessation may lead to a return of postoperative inflammation or pain; patients should discuss any abrupt changes with their eye care provider.
Routine follow-up after ocular surgery usually includes assessment of inflammation, pain control, and visual acuity. Specific laboratory monitoring is not required for the ophthalmic formulation, but clinicians may examine the eye for signs of delayed healing or adverse reactions at each postoperative visit.
This article provides educational information about Acular and is not a substitute for professional medical advice. Treatment decisions, including the use of this medication for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
